Avalon GloboCare Announces Execution of Purchase Agreement for Acquisition of SenlangBio in ...

Retrieved on: 2021-06-14 12:56:15

Tags for this article:

Click the tags to see associated articles and topics

Avalon GloboCare Announces Execution of Purchase Agreement for Acquisition of SenlangBio in .... View article details on hiswai:

Excerpt

SenlangBio's core technology platforms include chimeric antigen receptor (CAR) T-cells (CAR-T), allogeneic CAR Gamma Delta T-cells (CAR-γδT), ...

Article found on: www.globenewswire.com